ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q1SCImago #6,140Top JournalGold OA

Transboundary and Emerging Diseases

Acronym:tbed
•
Abbreviation (ISO):TRANSBOUNDARY EMERGING DIS
•
Identifier (ISSN):1865-1674(Print)/1865-1682(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
2.6↓ -0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Transboundary and Emerging Diseases

WoS Q3
13573.520183.5520194.192020520214.5220224.320233.52024320252.62026
Annual Impact Factor Metric
Current (2026):2.6
Scopus SJR & RankScopus Q1
0.865
#6,140

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
100

100 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
439articles/year
100% Gold OA•93.71% Original Research

Aims & Scope

Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions): Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread. Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope. Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies. Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies). Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.

Topics Covered (Recognized by AI)
Biology95.9%Medicine91.4%Virology79.1%Genetics77.8%Immunology71.2%Pathology63.2%Virus55%Veterinary medicine50.1%Chemistry46.9%Biochemistry45.5%Ecology45.3%Gene42.4%Internal medicine39%Geography32.7%Outbreak32.3%Environmental health25.1%Computer science24.6%Sociology23.7%Geology22.7%Microbiology22.1%Antibody21.1%Paleontology21%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

INFECTIOUS DISEASES

Q3
Rank71/141
IndexSCIE
JCRSCIE2026

VETERINARY SCIENCES

Q1
Rank33/170
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q1
Rank26/141
IndexSCIE
JCISCIE2026

VETERINARY SCIENCES

Q1
Rank26/170
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.6
Articles / Year250
Total Citations118
2025
IF3
Articles / Year257
Total Citations760
2024
IF3.5
Articles / Year186
Total Citations1,057
2023
IF4.3
Articles / Year180
Total Citations1,883
2022
IF4.521
Articles / Year338
Total Citations5,275

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,140Scopus Q1SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicineVeterinary
Scopus Citation Rank (SJR)Q1
0.865

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.50

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,285 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,660
3-Year Documents1,053
Citable Documents1,033

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)7

Citations in government and international policy documents

Female Author Rate41.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Veterinary (miscellaneous)Q1
Immunology and Microbiology (miscellaneous)Q2
Medicine (miscellaneous)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Agricultural Sciences
Minor Category (Specific Field):
3区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Transboundary and Emerging Diseases (acronym: tbed, abbr: TRANSBOUNDARY EMERGING DIS, ISSN: 1865-1674) is a peer-reviewed international scholarly journal in the field of Agricultural Sciences, published by Wiley-Blackwell Publishing Ltd in Germany since 2008. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.865 (Q1), an H-index of 100.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 439 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,285 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Monthly
Founding Year
2008
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 0487f7f7-0507-4b1a-a9b5-85eeb279a0c3
Database Updated: 2026-10-01